Seeking Alpha

BioBlast reports Q2 results

  • BioBlast Pharma (NASDAQ:ORPNQ2 results: Revenues: $0; Operating Expenses: $1.1M (+729.9%); Net Loss: ($1.1M) (-725.2%); Loss Per Share: ($0.10) (-400.0%); Quick Assets: $4.2M (+999%); Cash Burn: ($0.7M) (-690.5%).
  • No financial guidance given.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|